Results
|
|
1.
|
|
|
|
2.
|
|
|
|
3.
|
|
|
|
4.
|
|
|
|
5.
|
|
|
|
6.
|
|
|
|
7.
|
|
|
|
8.
|
FOLFIRI and sunitinib as first-line treatment in metastatic colorectal cancer patients with liver metastases--a CESAR phase II study including pharmacokinetic, biomarker, and imaging data. [electronic resource] by
- Mross, Klaus
- Scheulen, Max
- Strumberg, Dirk
- Kuhlmann, Jan
- Kanefendt, Friederike
- Sörgel, Fritz
- Jaehde, Ulrich
- Burkholder, Iris
- Moritz, Berta
- Büchert, Martin
Producer: 20140925
In:
International journal of clinical pharmacology and therapeutics vol. 52
Availability: No items available.
|
|
|
9.
|
|
|
|
10.
|
|
|
|
11.
|
Results of a phase II trial of S-1 as first-line treatment of metastatic pancreatic cancer (CESAR-study group). [electronic resource] by
- Schultheis, Beate
- Strumberg, Dirk
- Bergmann, Lothar
- Graeven, Ullrich
- Hanauske, Axel-Rainer
- Lipp, Rainer
- Schuette, Jochen
- Saito, K
- Scigalla, Paul
- Scheulen, Max E
Producer: 20120920
In:
Investigational new drugs vol. 30
Availability: No items available.
|
|
|
12.
|
Pharmacokinetics of a novel anticancer ruthenium complex (KP1019, FFC14A) in a phase I dose-escalation study. [electronic resource] by
- Lentz, Frederike
- Drescher, Anne
- Lindauer, Andreas
- Henke, Magdalena
- Hilger, Ralf A
- Hartinger, Christian G
- Scheulen, Max E
- Dittrich, Christian
- Keppler, Bernhard K
- Jaehde, Ulrich
Producer: 20090428
In:
Anti-cancer drugs vol. 20
Availability: No items available.
|
|
|
13.
|
A phase I study of BI 811283, an Aurora B kinase inhibitor, in patients with advanced solid tumors. [electronic resource] by
- Mross, Klaus
- Richly, Heike
- Frost, Annette
- Scharr, Dirk
- Nokay, Bahar
- Graeser, Ralph
- Lee, Chooi
- Hilbert, James
- Goeldner, Rainer-George
- Fietz, Oliver
- Scheulen, Max E
Producer: 20170606
In:
Cancer chemotherapy and pharmacology vol. 78
Availability: No items available.
|
|
|
14.
|
Phase I study of telatinib (BAY 57-9352): analysis of safety, pharmacokinetics, tumor efficacy, and biomarkers in patients with colorectal cancer. [electronic resource] by
- Mross, Klaus
- Frost, Annette
- Scheulen, Max E
- Krauss, Jürgen
- Strumberg, Dirk
- Schultheiss, Beate
- Fasol, Ulrike
- Büchert, Martin
- Krätzschmer, Jörn
- Delesen, Heinz
- Rajagopalan, Prabhu
- Christensen, Olaf
Producer: 20111110
In:
Vascular cell vol. 3
Availability: No items available.
|
|
|
15.
|
A Phase I study of pazopanib in combination with gemcitabine in patients with advanced solid tumors. [electronic resource] by
- Plummer, Ruth
- Madi, Ayman
- Jeffels, Melinda
- Richly, Heike
- Nokay, Bahar
- Rubin, Stephen
- Ball, Howard A
- Weller, Steve
- Botbyl, Jeffrey
- Gibson, Diana M
- Scheulen, Max E
Producer: 20130226
In:
Cancer chemotherapy and pharmacology vol. 71
Availability: No items available.
|
|
|
16.
|
Clinical Benefit and Health-Related Quality of Life Assessment in Patients Treated with Cisplatin/S-1 Versus Cisplatin/5-FU: Secondary End Point Results From the First-Line Advanced Gastric Cancer Study (FLAGS). [electronic resource] by
- Bodoky, György
- Scheulen, Max E
- Rivera, Fernando
- Jassem, Jacek
- Carrato, Alfredo
- Moiseyenko, Vladimir
- Vynnychenko, Ihor
- Prausová, Jana
- Van Laethem, Jean-Luc
- Cascinu, Stefano
- Ajani, Jaffer A
Producer: 20160225
In:
Journal of gastrointestinal cancer vol. 46
Availability: No items available.
|
|
|
17.
|
Phase I clinical and pharmacokinetic study of BBR 3576, a novel aza-anthrapyrazole, administered i.v. every 4 weeks in patients with advanced solid tumors: a phase I study group trial of the Central European Society of Anticancer-Drug Research (CESAR). [electronic resource] by
- Mross, Klaus
- Scheulen, Max E
- Licht, Thomas
- Unger, Clemens
- Richly, Heike
- Stern, Angelika C
- Kutz, Klaus
- Camboni, Maria G
- Barbieri, Paola
- Verdi, Elena
- Vincenzi, Beatrice
- Bernareggi, Alberto
Producer: 20041025
In:
Anti-cancer drugs vol. 15
Availability: No items available.
|
|
|
18.
|
A randomised, double-blind, placebo-controlled trial of trametinib, an oral MEK inhibitor, in combination with gemcitabine for patients with untreated metastatic adenocarcinoma of the pancreas. [electronic resource] by
- Infante, Jeffrey R
- Somer, Bradley G
- Park, Joon Oh
- Li, Chung-Pin
- Scheulen, Max E
- Kasubhai, Saifuddin M
- Oh, Do-Youn
- Liu, Yuan
- Redhu, Suman
- Steplewski, Klaudia
- Le, Ngocdiep
Producer: 20140826
In:
European journal of cancer (Oxford, England : 1990) vol. 50
Availability: No items available.
|
|
|
19.
|
Results of a phase I trial of sorafenib (BAY 43-9006) in combination with oxaliplatin in patients with refractory solid tumors, including colorectal cancer. [electronic resource] by
- Kupsch, Petra
- Henning, Bernhard F
- Passarge, Katrin
- Richly, Heike
- Wiesemann, Katrin
- Hilger, Ralf A
- Scheulen, Max E
- Christensen, Olaf
- Brendel, Erich
- Schwartz, Brian
- Hofstra, Elke
- Voigtmann, Rudolf
- Seeber, Siegfried
- Strumberg, Dirk
Producer: 20051207
In:
Clinical colorectal cancer vol. 5
Availability: No items available.
|
|
|
20.
|
Phase I clinical study of the toll-like receptor 9 agonist MGN1703 in patients with metastatic solid tumours. [electronic resource] by
- Weihrauch, Martin R
- Richly, Heike
- von Bergwelt-Baildon, Michael S
- Becker, Hans Jiro
- Schmidt, Manuel
- Hacker, Ulrich T
- Shimabukuro-Vornhagen, Alexander
- Holtick, Udo
- Nokay, Bahar
- Schroff, Matthias
- Wittig, Burghardt
- Scheulen, Max E
Producer: 20150427
In:
European journal of cancer (Oxford, England : 1990) vol. 51
Availability: No items available.
|